Celularity Inc. (CELU)
Celularity Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.
Celularity Inc. (CELU) is a Biotechnology company based in US with a market capitalization of $23.6M. Revenue declined 51.0% year-over-year and free cash flow was negative at -$13.3M. This page tracks CELU's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.
US · 120 employees · IPO Aug 8, 2019
Valuation
Valuation & price
$0.81as of May 17, 2026· -80.5% vs 52w high
—
P/E ratio
Latest-FY diluted EPS
—
P/B ratio
Market cap ÷ book equity
—
Dividend yield
Price — last 12 months
Fundamentals
Key fundamentals
$23.6M
Market cap
-51.0%
Revenue growth (YoY)
76.0%
Gross margin
-$13.3M
Free cash flow (USD)
$34.7M
Net debt
16.9%
Share dilution
0/4
Graham criteria passed
Defensive-investor screen
Healthcare
Sector
Trajectory
Long-term trends
Revenue by year
2018 → 2025
Free cash flow by year
2018 → 2025
Gross margin by year
2021 → 2025
Value screen
Graham defensive-investor tests
0
Insider buys · 90 days
0
Insider sells · 90 days
Earnings
Last report: 10-K filed Apr 30, 2026
Next expected: not yet scheduled
On the tape
Recent SEC & insider activity
- 8-K eventJun 30, 2026Filing
Loan Agreement
- 8-K eventJun 25, 2026Filing
Executive Appointments
- 8-K eventJun 12, 2026Filing
Delisting Notice
- 8-K eventJun 3, 2026Filing
Chief Commercial Officer Appointment
- 8-K eventMay 28, 2026Filing
Settlement Agreement
- Annual reportApr 30, 2026Filing
10-K Filed
- 8-K eventApr 21, 2026Filing
Convertible Note Issued
Questions
Frequently asked questions
What is Celularity Inc.'s market cap?
Celularity Inc. (CELU) has a market capitalization of $23.6M.
What is CELU's P/E ratio?
A meaningful P/E ratio is not available for CELU — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.
Are insiders buying CELU stock?
SEC Form 4 filings show no open-market insider buys at Celularity Inc. in the last 90 days (0 sells).
Same arena
Related companies in Biotechnology
Timeline
Every filing, insider trade & earnings on a price-anchored timeline
Filing Analyzer
Search the actual 10-K / 10-Q text with AI research angles
News
Latest press coverage in one feed
Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.